039860.KQ NanoenTekInc

Technology Life Sciences Tools & Services KOSDAQ
4,455 KRW
Close of Oct 30, 2026
3,015 9,390
Market cap
KRW 169B
P/E
30.1x
P/B
1.79x
ROE
7.6%
Dividend yield
-
Fundamental score
0.9/5

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 039860.KQ undervalued?

Graham number
Price4,455
Graham value2,875
Premium55.0%

039860.KQ trades 55.0% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NanoenTekInc fundamental analysis

5 of 22 checks passed

ROE 0/2

Low return on equity (7.6%), below 10%.

ROA 1/1

Return on assets (7.0%) is above the industry median (2.4%).

Profit Consistency 0/2

Not profitable for at least 3 consecutive years.

Earnings Growth 5Y 0/1

Earnings per share did not grow over the past 5 years.

Earnings Acceleration 0/1

Last year's EPS growth (-62.6%) is not above the 5-year average (-16.4% a year).

Earnings Growth vs Industry 0/1

Last year's EPS growth (-62.6%) is below the industry median (54.3%).

Revenue Growth 1/2

Revenue grew 2.7% a year over the past 3 years.

Short-term Liquidity 1/1

Current assets cover short-term liabilities.

Long-term Liabilities 1/1

Current assets cover long-term liabilities.

Debt to Equity 0/2

Debt to equity cannot be calculated: debt is not reported or equity is negative.

Debt Trend 0/1

Debt to equity has risen over the past 5 years.

Debt Coverage 0/1

Debt is not reported.

Interest Coverage 1/1

No interest expense reported.

PE vs Market 0/1

PE (30.1x) is above the market median (11.3x).

PE vs Industry 0/1

PE (30.1x) is above the industry median (11.3x).

PBV 0/1

Price to book (1.8x) is above the industry median (1.8x).

Graham Number 0/1

The price is above the Graham number (PE x PB = 54.0, limit 22.5).

PEG 0/1

PEG needs positive PE and positive 5-year earnings growth.

Dividend Yield 0/2

No dividend paid in the last reported year.

Dividend Stability 0/2

Dividends were not paid steadily for the past 5 years.

Dividend Growth 0/1

Dividends paid did not grow over the past 5 years.

Payout Ratio 0/1

No dividend, or no profit to pay it from.

Each check is worth 1 or 2 points by how much it says about the quality of the company. The score is the share of points earned, out of 5. Ask AI to explain this score

NanoenTekInc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NanoenTekInc

NanoEntek, Inc. engages in the research and development, production, and sale of life-science lab equipment, in vitro diagnostic medical devices, point of care diagnostic devices, and related consumables and solutions in Korea and internationally. It provides FREND system, a fluorescence immunoassay analyzer; BUDDI, a rapid diagnostic test analyzer; rapid diagnostic test items; ADAM-rWBC, a residual white blood cell counters; ADAMII/fluorescence stem cell counter; fluorescen…

Full company profile